FDA Announces “No Artificial Colors” Enforcement Discretion

The FDA has relaxed its enforcement stance on “no artificial colors” label claims.

Adobe Stock 487684483
Nickpd via Adobe Stock

The Food and Drug Administration (FDA)  announced on Feb. 5 that the agency will exercise enforcement discretion to allow “no artificial colors” and similar claims if artificial color is added, as long as it is not an FD&C certified color. 

This means the FDA doesn’t plan to take enforcement action against firms if they make a voluntary label claim of “no artificial color” to signal the absence of FD&C certified color.

Currently the definition of “artificial color” doesn’t distinguish between colors that are derived from natural sources and other colors. According to the FDA Commissioner, this change to labeling enforcement is intended to facilitate the transition away from FD&C-certified colors.

No mention is made of a plan to revise the law. 

Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026